Aglaya G. Iyevleva

2.3k total citations · 1 hit paper
78 papers, 1.5k citations indexed

About

Aglaya G. Iyevleva is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aglaya G. Iyevleva has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 38 papers in Oncology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aglaya G. Iyevleva's work include BRCA gene mutations in cancer (22 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Genomics and Diagnostics (19 papers). Aglaya G. Iyevleva is often cited by papers focused on BRCA gene mutations in cancer (22 papers), Lung Cancer Treatments and Mutations (20 papers) and Cancer Genomics and Diagnostics (19 papers). Aglaya G. Iyevleva collaborates with scholars based in Russia, Netherlands and Belarus. Aglaya G. Iyevleva's co-authors include Evgeny N. Imyanitov, E. Levchenko, Alexandr V. Togo, Anna P. Sokolenko, Natalia V. Mitiushkina, Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, Svetlana N. Aleksakhina, Evgeny N. Suspitsin and Dmitry E. Matsko and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Aglaya G. Iyevleva

68 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives

2020 339 citations Evgeny N. Imyanitov, Aglaya G. Iyevleva et al. Critical Reviews in Oncology/Hematology profile →

Peers

Aglaya G. Iyevleva

ONCOL

PRM

GENET

Samuli Hemmer Finland

Christina I. Herold United States

Friedrich Otterbach Germany

Anna P. Sokolenko Russia

J. S. Reis-Filho United Kingdom

Jong-Yeon Shin South Korea

S M Edgerton United States

Richard Letrero United States

Jacqui Rowbottom United Kingdom

Tuula Kuukasjärvi Finland

Samuli Hemmer Finland

Aglaya G. Iyevleva

694 ×1.0

410 ×0.7

ONCOL

340 ×0.7

213 ×0.5

PRM

473 ×1.0

GENET

Citations per year, relative to Aglaya G. Iyevleva Aglaya G. Iyevleva (= 1×) peers Samuli Hemmer

Countries citing papers authored by Aglaya G. Iyevleva

Since Specialization

Citations

This map shows the geographic impact of Aglaya G. Iyevleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aglaya G. Iyevleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aglaya G. Iyevleva more than expected).

Fields of papers citing papers by Aglaya G. Iyevleva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aglaya G. Iyevleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aglaya G. Iyevleva. The network helps show where Aglaya G. Iyevleva may publish in the future.

Co-authorship network of co-authors of Aglaya G. Iyevleva

This figure shows the co-authorship network connecting the top 25 collaborators of Aglaya G. Iyevleva. A scholar is included among the top collaborators of Aglaya G. Iyevleva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aglaya G. Iyevleva. Aglaya G. Iyevleva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iyevleva, Aglaya G., et al.. (2025). Analysis of homologous recombination deficiency in prostate cancer. Siberian Journal of Oncology. 24(1). 59–69.

Preobrazhenskaya, Elena V., Natalia V. Mitiushkina, Svetlana N. Aleksakhina, et al.. (2023). Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas. International Journal of Molecular Sciences. 24(13). 10530–10530. 6 indexed citations

Preobrazhenskaya, Elena V., et al.. (2023). Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples. International Journal of Molecular Sciences. 24(18). 14203–14203. 4 indexed citations

Yanus, Grigoriy A., Aglaya G. Iyevleva, Evgeny N. Suspitsin, et al.. (2023). Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies. SHILAP Revista de lepidopterología. 14(2). 5–20.

Iyevleva, Aglaya G., et al.. (2022). 25P Identification of novel kinase-activating fusions in non-small cell lung carcinomas (NSCLCs). Annals of Oncology. 33. S553–S554. 1 indexed citations

Orlov, Sergey, Aglaya G. Iyevleva, Е. А. Филиппова, et al.. (2021). Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study. Translational Oncology. 14(8). 101121–101121. 7 indexed citations

Imyanitov, Evgeny N. & Aglaya G. Iyevleva. (2021). Molecular tests for prediction of tumor sensitivity to cytotoxic drugs. Cancer Letters. 526. 41–52. 8 indexed citations

Preobrazhenskaya, Elena V., Aglaya G. Iyevleva, Natalia V. Mitiushkina, et al.. (2020). Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors. Pediatric Blood & Cancer. 67(5). e28220–e28220. 23 indexed citations

Yanus, Grigoriy A., et al.. (2020). MICROSATELLITE-UNSTABLE COLORECTAL CANCER IN ELDERLY PATIENTS: CLINICAL FEATURES AND THE ROLE OF IMMUNODEFICIENCY. SHILAP Revista de lepidopterología. 19(1). 31–39. 2 indexed citations

10.

Aleksakhina, Svetlana N., et al.. (2020). CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer. Clinical & Translational Oncology. 23(4). 874–881. 6 indexed citations

11.

Imyanitov, Evgeny N., Aglaya G. Iyevleva, & E. Levchenko. (2020). Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives. Critical Reviews in Oncology/Hematology. 157. 103194–103194. 339 indexed citations breakdown →

12.

Sokolenko, Anna P., et al.. (2018). MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER. SHILAP Revista de lepidopterología. 25(2). 7–18. 2 indexed citations

13.

Iyevleva, Aglaya G. & Evgeny N. Imyanitov. (2016). Cytotoxic and targeted therapy for hereditary cancers. Hereditary Cancer in Clinical Practice. 14(1). 41 indexed citations

14.

Mitiushkina, Natalia V., et al.. (2015). Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan. Journal of Gastrointestinal Cancer. 47(4). 502–505. 13 indexed citations

15.

Проценко, Светлана, et al.. (2015). Vemurafenib-induced progression of breast cancer: a case report and review of the literature. Targeted Oncology. 11(2). 235–238. 5 indexed citations

16.

Iyevleva, Aglaya G., Anna P. Sokolenko, Natalia V. Mitiushkina, et al.. (2015). Novel ALK fusion partners in lung cancer. Cancer Letters. 362(1). 116–121. 65 indexed citations

17.

Sokolenko, Anna P., Natalia Bogdanova, Wojciech Kluźniak, et al.. (2014). Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Research and Treatment. 145(2). 553–562. 45 indexed citations

18.

Yanus, Grigoriy A., Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, et al.. (2013). Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients. Medical Oncology. 30(3). 686–686. 43 indexed citations

19.

Iyevleva, Aglaya G., Ekatherina Sh. Kuligina, Natalia V. Mitiushkina, et al.. (2011). High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Breast Cancer Research and Treatment. 131(3). 1049–1059. 26 indexed citations

20.

Bogdanova, Natalia, Anna P. Sokolenko, Aglaya G. Iyevleva, et al.. (2010). PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Research and Treatment. 126(2). 545–550. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact